Clinical Importance of Expression of BIRC5 and HER2-Neu Genes in Circulating Tumor Cells as Markers of Minimum Residual Disease in Surgical Treatment of Breast Cancer | Zendy

AI Assistant Blog Pricing

Clinical Importance of Expression of BIRC5 and HER2-Neu Genes in Circulating Tumor Cells as Markers of Minimum Residual Disease in Surgical Treatment of Breast Cancer

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.